Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Long-term outcomes in lupus.

M Petri

    The American Journal of Managed Care
    |October 30, 2001
    PubMed
    Summary
    This summary is machine-generated.

    Systemic lupus erythematosus (SLE) management is challenging due to unpredictable flares and significant side effects from prednisone. New treatments are needed to reduce or replace steroid use in moderately affected patients.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Collapse of Nuclear Collectivity along the N=Z Line.

    Physical review letters·2026
    Same author

    Author Correction: An asymmetric fission island driven by shell effects in light fragments.

    Nature·2025
    Same author

    An asymmetric fission island driven by shell effects in light fragments.

    Nature·2025
    Same author

    Electromagnetic properties of nuclei from first principles: a case for synergies between experiment and theory.

    Philosophical transactions. Series A, Mathematical, physical, and engineering sciences·2024
    Same author

    Study of the N=32 and N=34 Shell Gap for Ti and V by the First High-Precision Multireflection Time-of-Flight Mass Measurements at BigRIPS-SLOWRI.

    Physical review letters·2023
    Same author

    The clinical and serological associations of hypocomplementemia in a longitudinal sle cohort.

    Seminars in arthritis and rheumatism·2020
    Same journal

    Prescription drug prior authorization: costs to pharmacies and physicians.

    The American journal of managed care·2026
    Same journal

    Combined pharmacotherapy and psychotherapy impact on opioid use disorder treatment.

    The American journal of managed care·2026
    Same journal

    The societal costs of food insecurity: implications for managed care strategies.

    The American journal of managed care·2026
    Same journal

    Availability of hospital financial assistance documents in non-English languages.

    The American journal of managed care·2026
    Same journal

    Real-world weight loss with injectable semaglutide vs dulaglutide for diabetes.

    The American journal of managed care·2026
    Same journal

    Social needs screening and supplemental benefits in Medicare Advantage.

    The American journal of managed care·2026
    See all related articles

    Area of Science:

    • Rheumatology
    • Immunology
    • Pharmacology

    Background:

    • Systemic lupus erythematosus (SLE) presents with unpredictable chronic or relapsing-remitting courses.
    • Current disease activity assessments lack predictive power for flares and complications.
    • Adverse effects of SLE, including musculoskeletal, renal, cardiovascular, and ocular issues, are often linked to prednisone treatment.

    Purpose of the Study:

    • To address the need for improved prediction of SLE disease flares and complications.
    • To evaluate alternative treatment strategies to minimize corticosteroid use in SLE patients.
    • To identify medications that can reduce or eliminate the reliance on prednisone for moderate SLE cases.

    Main Methods:

    • Review of current SLE disease activity assessment tools.

    Related Experiment Videos

  • Analysis of adverse event data associated with prednisone therapy in SLE.
  • Comparison of pulsed-dose methylprednisolone versus increased daily prednisone for flare management.

    • Main Results:

    • Existing measures for SLE disease activity are insufficient for predicting flares.
    • Pulsed-dose methylprednisolone may pose less risk than escalating daily prednisone doses during flares.
    • A significant need exists for steroid-sparing medications in moderate SLE.

    Conclusions:

    • Current SLE management strategies require enhancement for flare prediction.
    • Pulsed-dose methylprednisolone offers a potentially safer alternative to increased daily prednisone.
    • Development of novel, steroid-sparing therapies is crucial for improving outcomes in moderate SLE.